更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
龙沙确认与美国生物制药基地达成“长期商业供应协议”——Investing.com
Lonza confirms "long-term commercial supply agreement" at U.S. biologic drug site Investing.com
收益电话会议记录:龙沙集团2025年第三季度CDMO业务强劲增长 - Investing.com
Earnings call transcript: Lonza Group Q3 2025 sees strong CDMO growth Investing.com
龙沙新购加州生物制剂厂在销售反弹中扮演关键角色——Fierce Pharma报道
Lonza's recently purchased Calif. biologics site plays key role in sales rebound Fierce Pharma
龙沙集团公布2025年第三季度业绩强劲,并确认全年展望——TipRanks
Lonza Reports Strong Q3 2025 and Confirms Full-Year Outlook TipRanks
龙沙集团2025年第三季度业绩强劲,并确认其CDMO与CHI业务全年展望——TradingView
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses TradingView
龙沙确认前景预期,预计未来数月将获更多合同——路透社
Lonza confirms outlook as it expects more contracts in coming months Reuters
CPHI 2025:龙沙Capsugel聚焦营养保健品递送技术与可持续发展——营养洞察网报道
CPHI 2025: Lonza Capsugel spotlights delivery tech and sustainability in nutraceuticals nutritioninsight.com
GBCC与龙沙合作启动学徒计划——新罕布什尔商业评论
GBCC and Lonza partner for apprenticeship program NH Business Review
龙沙扩大其细胞与基因疗法GMP解决方案——精选科学报道
Lonza expands its GMP solutions for cell and gene therapy SelectScience
Lonza Capsugel推出有机素食胶囊系列——供应方补充期刊
Lonza Capsugel launches organic, vegan capsule line SupplySide Supplement Journal
龙沙获瑞士药监局批准在斯坦因(瑞士)设立高效生物制剂药品灌装生产线 - the-scientist.com
Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH) the-scientist.com
现在是审视龙沙集团股份公司(VTX:LONN)的良机吗?——雅虎财经
Is Now An Opportune Moment To Examine Lonza Group AG (VTX:LONN)? Yahoo Finance
龙沙集团:增长迹象与估值过高,新管理层带来不确定性 - 寻求阿尔法
Lonza Group: Growth, Signs Of Overvaluation, And A New Management Cause Uncertainty Seeking Alpha
龙沙集团在瑞士斯坦完成新药品灌装生产线建设——合同制药报道
Lonza Completes New Drug Product Filling Line in Stein, Switzerland Contract Pharma
2025-2033年生物技术市场治疗创新与预测报告:聚焦龙沙、安进、先正达、百康、百健、罗氏、诺华、诺和诺德、辉瑞及西雅图遗传学公司 - ResearchAndMarkets.com - 商业电讯
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk...
龙沙扩大细胞与基因治疗产品组合 - 合同制药
Lonza Expands Cell and Gene Therapy Portfolio Contract Pharma
Lonza在SupplySide全球展上宣布创新日活动——《WholeFoods》杂志报道
Lonza Announces Innovation Day at SupplySide Global WholeFoods Magazine
龙沙宣布新董事会提名候选人——《瓦卡维尔记者报》
Lonza announces new board nominee The Vacaville Reporter
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页